Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis. by Sevan N Alwan, Alexander B Taylor, Jayce Rhodes, Michael Tidwell, Stanton F McHardy, Philip T LoVerde

Get full text

Rational approach to drug discovery for human schistosomiasis by Philip T. LoVerde, Sevan N. Alwan, Alexander B. Taylor, Jayce Rhodes, Frédéric D. Chevalier, Timothy JC. Anderson, Stanton F. McHardy

Get full text

Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147] by Philip T. LoVerde, Sevan N. Alwan, Alexander B. Taylor, Jayce Rhodes, Frédéric D. Chevalier, Timothy Jc Anderson, Stanton F. McHardy

Get full text

Schistosome Sulfotransferases: Mode of Action, Expression and Localization by Meghan A. Guzman, Anastasia Rugel, Sevan N. Alwan, Reid Tarpley, Alexander B. Taylor, Frédéric D. Chevalier, George R. Wendt, James J. Collins, Timothy J. C. Anderson, Stanton F. McHardy, Philip T. LoVerde

Get full text

An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans. by Meghan A Guzman, Anastasia R Rugel, Reid S Tarpley, Sevan N Alwan, Frédéric D Chevalier, Dmytro P Kovalskyy, Xiaohang Cao, Stephen P Holloway, Timothy J C Anderson, Alexander B Taylor, Stanton F McHardy, Philip T LoVerde

Get full text